Report cover image

Global Pefloxacin Mesylate Market Analysis and Forecast 2025-2031

Publisher APO Research, Inc.
Published Aug 16, 2025
Length 196 Pages
SKU # APRC20362268

Description

Summary

According to APO Research, The global Pefloxacin Mesylate market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Pefloxacin Mesylate is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Pefloxacin Mesylate is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Pefloxacin Mesylate is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Pefloxacin Mesylate is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Pefloxacin Mesylate include AdvaCare Pharma, Beijing Shuanglu Pharmaceutical Co., Ltd., Beijing Sihuan Pharmaceutical Co., Ltd., China Resources Shuanghe Limin Pharmaceutical (Jinan) Co., Ltd., CommScope Pharmaceutical Co., Ltd., Ruiyang Pharmaceutical Co., Ltd., Shandong Lukang Pharmaceutical Group Saite Co., Ltd. and Yichang Renfu Pharmaceutical Co., Ltd., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Pefloxacin Mesylate, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Pefloxacin Mesylate, also provides the sales of main regions and countries. Of the upcoming market potential for Pefloxacin Mesylate, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Pefloxacin Mesylate sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Pefloxacin Mesylate market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Pefloxacin Mesylate sales, projected growth trends, production technology, application and end-user industry.

Pefloxacin Mesylate Segment by Company

AdvaCare Pharma
Beijing Shuanglu Pharmaceutical Co., Ltd.
Beijing Sihuan Pharmaceutical Co., Ltd.
China Resources Shuanghe Limin Pharmaceutical (Jinan) Co., Ltd.
CommScope Pharmaceutical Co., Ltd.
Ruiyang Pharmaceutical Co., Ltd.
Shandong Lukang Pharmaceutical Group Saite Co., Ltd.
Yichang Renfu Pharmaceutical Co., Ltd.
Pefloxacin Mesylate Segment by Type

Capsule
Tablet
Injection
Pefloxacin Mesylate Segment by Application

Hospital Pharmacy
Retail Pharmacy
Others
Pefloxacin Mesylate Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pefloxacin Mesylate market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pefloxacin Mesylate and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pefloxacin Mesylate.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Pefloxacin Mesylate in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Pefloxacin Mesylate manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pefloxacin Mesylate sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.

Table of Contents

196 Pages
1 Market Overview
1.1 Product Definition
1.2 Pefloxacin Mesylate Market by Type
1.2.1 Global Pefloxacin Mesylate Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Capsule
1.2.3 Tablet
1.2.4 Injection
1.3 Pefloxacin Mesylate Market by Application
1.3.1 Global Pefloxacin Mesylate Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Pefloxacin Mesylate Market Dynamics
2.1 Pefloxacin Mesylate Industry Trends
2.2 Pefloxacin Mesylate Industry Drivers
2.3 Pefloxacin Mesylate Industry Opportunities and Challenges
2.4 Pefloxacin Mesylate Industry Restraints
3 Global Market Growth Prospects
3.1 Global Pefloxacin Mesylate Revenue Estimates and Forecasts (2020-2031)
3.2 Global Pefloxacin Mesylate Revenue by Region
3.2.1 Global Pefloxacin Mesylate Revenue by Region: 2020 VS 2024 VS 2031
3.2.2 Global Pefloxacin Mesylate Revenue by Region (2020-2025)
3.2.3 Global Pefloxacin Mesylate Revenue by Region (2026-2031)
3.2.4 Global Pefloxacin Mesylate Revenue Market Share by Region (2020-2031)
3.3 Global Pefloxacin Mesylate Sales Estimates and Forecasts 2020-2031
3.4 Global Pefloxacin Mesylate Sales by Region
3.4.1 Global Pefloxacin Mesylate Sales by Region: 2020 VS 2024 VS 2031
3.4.2 Global Pefloxacin Mesylate Sales by Region (2020-2025)
3.4.3 Global Pefloxacin Mesylate Sales by Region (2026-2031)
3.4.4 Global Pefloxacin Mesylate Sales Market Share by Region (2020-2031)
3.5 US & Canada & Mexico
3.6 Europe
3.7 China
3.8 Asia (Excluding China)
3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
4.1 Global Pefloxacin Mesylate Revenue by Manufacturers
4.1.1 Global Pefloxacin Mesylate Revenue by Manufacturers (2020-2025)
4.1.2 Global Pefloxacin Mesylate Revenue Market Share by Manufacturers (2020-2025)
4.1.3 Global Pefloxacin Mesylate Manufacturers Revenue Share Top 10 and Top 5 in 2024
4.2 Global Pefloxacin Mesylate Sales by Manufacturers
4.2.1 Global Pefloxacin Mesylate Sales by Manufacturers (2020-2025)
4.2.2 Global Pefloxacin Mesylate Sales Market Share by Manufacturers (2020-2025)
4.2.3 Global Pefloxacin Mesylate Manufacturers Sales Share Top 10 and Top 5 in 2024
4.3 Global Pefloxacin Mesylate Sales Price by Manufacturers (2020-2025)
4.4 Global Pefloxacin Mesylate Key Manufacturers Ranking, 2023 VS 2024 VS 2025
4.5 Global Pefloxacin Mesylate Key Manufacturers Manufacturing Sites & Headquarters
4.6 Global Pefloxacin Mesylate Manufacturers, Product Type & Application
4.7 Global Pefloxacin Mesylate Manufacturers' Establishment Date
4.8 Market Competitive Analysis
4.8.1 Global Pefloxacin Mesylate Market CR5 and HHI
4.8.2 2024 Pefloxacin Mesylate Tier 1, Tier 2, and Tier 3
5 Pefloxacin Mesylate Market by Type
5.1 Global Pefloxacin Mesylate Revenue by Type
5.1.1 Global Pefloxacin Mesylate Revenue by Type (2020 VS 2024 VS 2031)
5.1.2 Global Pefloxacin Mesylate Revenue by Type (2020-2031) & (US$ Million)
5.1.3 Global Pefloxacin Mesylate Revenue Market Share by Type (2020-2031)
5.2 Global Pefloxacin Mesylate Sales by Type
5.2.1 Global Pefloxacin Mesylate Sales by Type (2020 VS 2024 VS 2031)
5.2.2 Global Pefloxacin Mesylate Sales by Type (2020-2031) & (K Units)
5.2.3 Global Pefloxacin Mesylate Sales Market Share by Type (2020-2031)
5.3 Global Pefloxacin Mesylate Price by Type
6 Pefloxacin Mesylate Market by Application
6.1 Global Pefloxacin Mesylate Revenue by Application
6.1.1 Global Pefloxacin Mesylate Revenue by Application (2020 VS 2024 VS 2031)
6.1.2 Global Pefloxacin Mesylate Revenue by Application (2020-2031) & (US$ Million)
6.1.3 Global Pefloxacin Mesylate Revenue Market Share by Application (2020-2031)
6.2 Global Pefloxacin Mesylate Sales by Application
6.2.1 Global Pefloxacin Mesylate Sales by Application (2020 VS 2024 VS 2031)
6.2.2 Global Pefloxacin Mesylate Sales by Application (2020-2031) & (K Units)
6.2.3 Global Pefloxacin Mesylate Sales Market Share by Application (2020-2031)
6.3 Global Pefloxacin Mesylate Price by Application
7 Company Profiles
7.1 AdvaCare Pharma
7.1.1 AdvaCare Pharma Comapny Information
7.1.2 AdvaCare Pharma Business Overview
7.1.3 AdvaCare Pharma Pefloxacin Mesylate Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 AdvaCare Pharma Pefloxacin Mesylate Product Portfolio
7.1.5 AdvaCare Pharma Recent Developments
7.2 Beijing Shuanglu Pharmaceutical Co., Ltd.
7.2.1 Beijing Shuanglu Pharmaceutical Co., Ltd. Comapny Information
7.2.2 Beijing Shuanglu Pharmaceutical Co., Ltd. Business Overview
7.2.3 Beijing Shuanglu Pharmaceutical Co., Ltd. Pefloxacin Mesylate Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Beijing Shuanglu Pharmaceutical Co., Ltd. Pefloxacin Mesylate Product Portfolio
7.2.5 Beijing Shuanglu Pharmaceutical Co., Ltd. Recent Developments
7.3 Beijing Sihuan Pharmaceutical Co., Ltd.
7.3.1 Beijing Sihuan Pharmaceutical Co., Ltd. Comapny Information
7.3.2 Beijing Sihuan Pharmaceutical Co., Ltd. Business Overview
7.3.3 Beijing Sihuan Pharmaceutical Co., Ltd. Pefloxacin Mesylate Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Beijing Sihuan Pharmaceutical Co., Ltd. Pefloxacin Mesylate Product Portfolio
7.3.5 Beijing Sihuan Pharmaceutical Co., Ltd. Recent Developments
7.4 China Resources Shuanghe Limin Pharmaceutical (Jinan) Co., Ltd.
7.4.1 China Resources Shuanghe Limin Pharmaceutical (Jinan) Co., Ltd. Comapny Information
7.4.2 China Resources Shuanghe Limin Pharmaceutical (Jinan) Co., Ltd. Business Overview
7.4.3 China Resources Shuanghe Limin Pharmaceutical (Jinan) Co., Ltd. Pefloxacin Mesylate Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 China Resources Shuanghe Limin Pharmaceutical (Jinan) Co., Ltd. Pefloxacin Mesylate Product Portfolio
7.4.5 China Resources Shuanghe Limin Pharmaceutical (Jinan) Co., Ltd. Recent Developments
7.5 CommScope Pharmaceutical Co., Ltd.
7.5.1 CommScope Pharmaceutical Co., Ltd. Comapny Information
7.5.2 CommScope Pharmaceutical Co., Ltd. Business Overview
7.5.3 CommScope Pharmaceutical Co., Ltd. Pefloxacin Mesylate Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 CommScope Pharmaceutical Co., Ltd. Pefloxacin Mesylate Product Portfolio
7.5.5 CommScope Pharmaceutical Co., Ltd. Recent Developments
7.6 Ruiyang Pharmaceutical Co., Ltd.
7.6.1 Ruiyang Pharmaceutical Co., Ltd. Comapny Information
7.6.2 Ruiyang Pharmaceutical Co., Ltd. Business Overview
7.6.3 Ruiyang Pharmaceutical Co., Ltd. Pefloxacin Mesylate Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Ruiyang Pharmaceutical Co., Ltd. Pefloxacin Mesylate Product Portfolio
7.6.5 Ruiyang Pharmaceutical Co., Ltd. Recent Developments
7.7 Shandong Lukang Pharmaceutical Group Saite Co., Ltd.
7.7.1 Shandong Lukang Pharmaceutical Group Saite Co., Ltd. Comapny Information
7.7.2 Shandong Lukang Pharmaceutical Group Saite Co., Ltd. Business Overview
7.7.3 Shandong Lukang Pharmaceutical Group Saite Co., Ltd. Pefloxacin Mesylate Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Shandong Lukang Pharmaceutical Group Saite Co., Ltd. Pefloxacin Mesylate Product Portfolio
7.7.5 Shandong Lukang Pharmaceutical Group Saite Co., Ltd. Recent Developments
7.8 Yichang Renfu Pharmaceutical Co., Ltd.
7.8.1 Yichang Renfu Pharmaceutical Co., Ltd. Comapny Information
7.8.2 Yichang Renfu Pharmaceutical Co., Ltd. Business Overview
7.8.3 Yichang Renfu Pharmaceutical Co., Ltd. Pefloxacin Mesylate Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 Yichang Renfu Pharmaceutical Co., Ltd. Pefloxacin Mesylate Product Portfolio
7.8.5 Yichang Renfu Pharmaceutical Co., Ltd. Recent Developments
8 North America
8.1 North America Pefloxacin Mesylate Market Size by Type
8.1.1 North America Pefloxacin Mesylate Revenue by Type (2020-2031)
8.1.2 North America Pefloxacin Mesylate Sales by Type (2020-2031)
8.1.3 North America Pefloxacin Mesylate Price by Type (2020-2031)
8.2 North America Pefloxacin Mesylate Market Size by Application
8.2.1 North America Pefloxacin Mesylate Revenue by Application (2020-2031)
8.2.2 North America Pefloxacin Mesylate Sales by Application (2020-2031)
8.2.3 North America Pefloxacin Mesylate Price by Application (2020-2031)
8.3 North America Pefloxacin Mesylate Market Size by Country
8.3.1 North America Pefloxacin Mesylate Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
8.3.2 North America Pefloxacin Mesylate Sales by Country (2020 VS 2024 VS 2031)
8.3.3 North America Pefloxacin Mesylate Price by Country (2020-2031)
8.3.4 United States
8.3.5 Canada
9 Europe
9.1 Europe Pefloxacin Mesylate Market Size by Type
9.1.1 Europe Pefloxacin Mesylate Revenue by Type (2020-2031)
9.1.2 Europe Pefloxacin Mesylate Sales by Type (2020-2031)
9.1.3 Europe Pefloxacin Mesylate Price by Type (2020-2031)
9.2 Europe Pefloxacin Mesylate Market Size by Application
9.2.1 Europe Pefloxacin Mesylate Revenue by Application (2020-2031)
9.2.2 Europe Pefloxacin Mesylate Sales by Application (2020-2031)
9.2.3 Europe Pefloxacin Mesylate Price by Application (2020-2031)
9.3 Europe Pefloxacin Mesylate Market Size by Country
9.3.1 Europe Pefloxacin Mesylate Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
9.3.2 Europe Pefloxacin Mesylate Sales by Country (2020 VS 2024 VS 2031)
9.3.3 Europe Pefloxacin Mesylate Price by Country (2020-2031)
9.3.4 Germany
9.3.5 France
9.3.6 U.K.
9.3.7 Italy
9.3.8 Netherlands
9.3.9 Nordic Countries
10 China
10.1 China Pefloxacin Mesylate Market Size by Type
10.1.1 China Pefloxacin Mesylate Revenue by Type (2020-2031)
10.1.2 China Pefloxacin Mesylate Sales by Type (2020-2031)
10.1.3 China Pefloxacin Mesylate Price by Type (2020-2031)
10.2 China Pefloxacin Mesylate Market Size by Application
10.2.1 China Pefloxacin Mesylate Revenue by Application (2020-2031)
10.2.2 China Pefloxacin Mesylate Sales by Application (2020-2031)
10.2.3 China Pefloxacin Mesylate Price by Application (2020-2031)
11 Asia (Excluding China)
11.1 Asia Pefloxacin Mesylate Market Size by Type
11.1.1 Asia Pefloxacin Mesylate Revenue by Type (2020-2031)
11.1.2 Asia Pefloxacin Mesylate Sales by Type (2020-2031)
11.1.3 Asia Pefloxacin Mesylate Price by Type (2020-2031)
11.2 Asia Pefloxacin Mesylate Market Size by Application
11.2.1 Asia Pefloxacin Mesylate Revenue by Application (2020-2031)
11.2.2 Asia Pefloxacin Mesylate Sales by Application (2020-2031)
11.2.3 Asia Pefloxacin Mesylate Price by Application (2020-2031)
11.3 Asia Pefloxacin Mesylate Market Size by Country
11.3.1 Asia Pefloxacin Mesylate Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
11.3.2 Asia Pefloxacin Mesylate Sales by Country (2020 VS 2024 VS 2031)
11.3.3 Asia Pefloxacin Mesylate Price by Country (2020-2031)
11.3.4 Japan
11.3.5 South Korea
11.3.6 India
11.3.7 Australia
11.3.8 Taiwan
11.3.9 Southeast Asia
12 South America, Middle East and Africa
12.1 SAMEA Pefloxacin Mesylate Market Size by Type
12.1.1 SAMEA Pefloxacin Mesylate Revenue by Type (2020-2031)
12.1.2 SAMEA Pefloxacin Mesylate Sales by Type (2020-2031)
12.1.3 SAMEA Pefloxacin Mesylate Price by Type (2020-2031)
12.2 SAMEA Pefloxacin Mesylate Market Size by Application
12.2.1 SAMEA Pefloxacin Mesylate Revenue by Application (2020-2031)
12.2.2 SAMEA Pefloxacin Mesylate Sales by Application (2020-2031)
12.2.3 SAMEA Pefloxacin Mesylate Price by Application (2020-2031)
12.3 SAMEA Pefloxacin Mesylate Market Size by Country
12.3.1 SAMEA Pefloxacin Mesylate Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
12.3.2 SAMEA Pefloxacin Mesylate Sales by Country (2020 VS 2024 VS 2031)
12.3.3 SAMEA Pefloxacin Mesylate Price by Country (2020-2031)
12.3.4 Brazil
12.3.5 Argentina
12.3.6 Chile
12.3.7 Colombia
12.3.8 Peru
12.3.9 Saudi Arabia
12.3.10 Israel
12.3.11 UAE
12.3.12 Turkey
12.3.13 Iran
12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
13.1 Pefloxacin Mesylate Value Chain Analysis
13.1.1 Pefloxacin Mesylate Key Raw Materials
13.1.2 Raw Materials Key Suppliers
13.1.3 Manufacturing Cost Structure
13.1.4 Pefloxacin Mesylate Production Mode & Process
13.2 Pefloxacin Mesylate Sales Channels Analysis
13.2.1 Direct Comparison with Distribution Share
13.2.2 Pefloxacin Mesylate Distributors
13.2.3 Pefloxacin Mesylate Customers
14 Concluding Insights
15 Appendix
15.1 Reasons for Doing This Study
15.2 Research Methodology
15.3 Research Process
15.4 Authors List of This Report
15.5 Data Source
15.5.1 Secondary Sources
15.5.2 Primary Sources
15.6 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.